At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 45 enrolled
Drug / intervention
Fentanyl +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2 Multicenter, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain
In Brief
A Phase 2 clinical trial evaluating Fentanyl and Placebo for Pain. Completed, enrolled 45 participants across 2 sites.
Detailed Summary
The primary objective of this trial is to evaluate analgesic efficacy of Fentanyl Sublingual Spray compared with placebo in participants with postoperative pain after a bunionectomy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartDec 2016
Primary CompletionFeb 2017
TodayJul 2026
First PostedSep 27, 2016
Enrollment StartDec 1, 2016
Primary CompletionFeb 10, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.8 years ago
Interventions
Fentanyldrug
Fentanyl delivered via sublingual spray
Placebodrug
Matching placebo delivered via sublingual spray